Q2 FY2026 · ended Jun 30, 2026 · Revenue $241,000, +129.5% YoY · Filed Aug 11, 2026
Microbot Medical Inc. (MBOT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $241,000 and a net loss of $5.6 million. Free cash flow was -$5.1 million. As of Jun 30, 2026 it held $67.4 million in cash and investments and $876,000 in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MBOT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hingham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 883975
- Former names
- Microbot Medical Inc. (until Nov 3, 2026); STEMCELLS INC (until Nov 15, 2016); CYTOTHERAPEUTICS INC/DE (until May 15, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $241,000 | $105,000 | — | — | — |
| Operating income | -$6.2M | -$4.3M | -$4.1M | -$3.9M | -$3.7M |
| Net income | -$5.6M | -$3.7M | -$3.5M | -$3.6M | -$3.5M |
| Diluted EPS | -$0.08 | -$0.05 | -$0.05 | -$0.07 | -$0.10 |
| Operating cash flow | -$5.0M | -$5.1M | -$3.8M | -$3.8M | -$2.6M |
| Free cash flow | -$5.1M | -$5.2M | -$3.8M | -$3.9M | -$2.6M |
| Total assets | $73.4M | $78.1M | $81.5M | $81.8M | $33.1M |
| Total liabilities | $4.4M | $4.0M | $4.0M | $3.5M | $2.8M |
| Stockholders' equity | $68.9M | $74.1M | $77.6M | $78.2M | $30.4M |
| Cash and investments | $67.4M | $72.5M | $78.6M | $80.2M | $32.7M |
| Total debt | $876,000 | $898,000 | $865,000 | $899,000 | $149,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Nov 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 20, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2026 | Sep 25, 2026 |
All 1004 Microbot Medical Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.